BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 26537683)

  • 1. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
    Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
    J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
    J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
    J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
    Williams LR; Quinn LL; Rowe M; Zuo J
    J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.
    Morrison TE; Mauser A; Klingelhutz A; Kenney SC
    J Virol; 2004 Jan; 78(1):544-9. PubMed ID: 14671137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR; Kwek SS; Kenney SC
    PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
    Kusano S; Ikeda M
    J Biol Chem; 2019 Oct; 294(41):15104-15116. PubMed ID: 31434743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
    Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
    J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE
    PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
    Hahn AM; Huye LE; Ning S; Webster-Cyriaque J; Pagano JS
    J Virol; 2005 Aug; 79(15):10040-52. PubMed ID: 16014964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
    Fu W; Verma D; Burton A; Swaminathan S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
    Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.